ReConstruct Bio is developing a next-generation approach to breast reconstruction for cancer survivors. Spun out of Harvard's Wyss Institute, the company uses proprietary 3D bioprinting technology to create vascularized fat tissue implants from a patient's own cells — offering a natural, permanent alternative to synthetic implants and complex flap surgeries.